Pops Diabetes Care said this week that the FDA cleared its Pops! one blood glucose monitoring system. The Minneapolis-based company’s device can be attached directly to the back of a mobile phone and interacts with the user through a coaching app. The Pops! one system also allows users to review their blood glucose trends and […]
Pops Diabetes Care reportedly enrolled the first patient in a clinical trial evaluating its Pops! one glucometer, according to the StarTribune. The Twin Cities-based company is said to be partnering with the Children’s Minnesota healthcare system to study its device in 50 Type I diabetes patients. Get the full story at our sister site, MassDevice.